Market Place
Sourcing Support
CPhI Milan - we had a great show
24 Oct 2024 //
PRESS RELEASE
Gx Inbeneo® autoinjector wins the Red Dot Award
22 Oct 2024 //
PRESS RELEASE
Roofing Ceremony for new office building at Midas Pharma
17 Oct 2024 //
PRESS RELEASE
Onboarding-week at Midas
11 Sep 2024 //
PRESS RELEASE
German-Malaysian Forum: Healthcare Sector Strategies & Opportunities
27 Aug 2024 //
PRESS RELEASE
German-Malaysian Forum: Strategies and opportunities in the healthcare sector
27 Aug 2024 //
PRESS RELEASE
Midas meets Charity 2024
14 Jun 2024 //
PRESS RELEASE
The NIS 2 Directive at Midas Pharma
04 Jun 2024 //
PRESS RELEASE
Portfolio of Biotech Services
29 May 2024 //
PRESS RELEASE
Midas Chemicals at Chemspec Europe in Düsseldorf, Booth H60
23 May 2024 //
PRESS RELEASE
New publication on the Gx Inbeneo Autoinjector
16 May 2024 //
PRESS RELEASE
Midas Runs for Charity 2024
05 May 2024 //
PRESS RELEASE
New Midas Legal Entity in China
11 Apr 2024 //
PRESS RELEASE
Midas Team Readies For Pharma-Cup 2024 Soccer Challenge
20 Mar 2024 //
PRESS RELEASE
Behind the scenes: Video shoot at Midas Pharma
28 Feb 2024 //
PRESS RELEASE
New Publication on the Gx Inbeneo® Platform Simulator
18 Jan 2024 //
PRESS RELEASE
New development partnership with Apontis Pharma
12 Dec 2023 //
PRESS RELEASE
New Cooperation Agreement with HERMES PHARMA
25 Sep 2023 //
PRESS RELEASE
Ranibizumab Launch Midas Pharma is the Marketing Authorisation Holder (MAH) of a biosimilar
25 Sep 2023 //
PRESS RELEASE
Midas uses IPMA standards in project management
15 Jun 2023 //
PRESS RELEASE
Midas`s Ranivisio (Ranibizumab) Receives Approval in Europe
05 Oct 2022 //
EMA
Midas Pharma engages in the Working Group „Health in Asia“ of the OAV and GHA
05 Jul 2022 //
PRESS RELEASE
Midas Pharma receives CEP for Propofol
23 Feb 2022 //
PRESS RELEASE
Midas` API "Crotamiton" has been successfully approved in China
01 Feb 2022 //
PRESS RELEASE
Midas Pharma obtains CEP for Clofazimine
28 Dec 2021 //
PRESS RELEASE
Midas Pharma and Gerresheimer announce strategic partnership
09 Nov 2021 //
PRESS RELEASE
EU Repatriation of APIs and Intermediates – Midas contributes to supply chain resiliency
01 Apr 2021 //
PRESS RELEASE
Outsourcing of key intermediates of APIs to increase market competitiveness
15 Feb 2021 //
PRESS RELEASE
STADA and Midas Pharma: Driving procurement forward together
18 Dec 2020 //
PRESS RELEASE
From lab development to commercial API production
11 Apr 2020 //
PRESS RELEASE
Coripharma and Midas to cooperate on sales & marketing
03 Feb 2020 //
PRESS RELEASE
